This publication series explores “Software as a Medical Device (SaMD),” its challenges and the ways regulatory bodies try to address them, as well as the expected development of regulations related…
Keeping Pace with Real-World Evidence: Evolving Software Regulations and the Growing Application of Artificial Intelligence
This white paper explores the increasing spotlight on the use of real world evidence, what regulators are looking for, and how AI-powered applications are rising in the field of digital…
This report from PwC presents three growth strategies to empower medtech companies to win in this competitive and rapidly changing environment.
Alexander Group surveyed digital, marketing, sales and service leaders across industries, and identified five key insights about the state of the Digital Revenue Organization post-pandemic.
This white paper from IQVIA explores a specific case study in South Korea and Germany, highlighting the driving role of the particularities of a patient population and the decisive role…
Listen to AdvaMed's Podcast
Brought to you by AdvaMed, MedTech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
A false emerging narrative suggests ethylene oxide (EtO) sterilization is cheaper, easier, and faster than alternatives and thus preferred. Get the facts on the cost of EtO.
The VALID Act is carefully tailored to ensure continued access to tests offered by academic medical centers and other laboratories.
This white paper from IQVIA – an associate member of AdvaMed – discusses how global markets and specific therapeutic areas are poised for growth over the next decade.
Lucy Fraiser, Ph.D., a board-certified toxicologist, recently responded in a letter to the editor of Modern Healthcare about the publication’s recent coverage of the EPA’s work on ethylene oxide.